U.S. FDA approves Roche's HPV self-testing kit for early cervical cancer detection.
The U.S. FDA has approved Roche's HPV self-testing kit. The Swiss pharmaceutical company's product helps detect HPV, a significant indicator for early cervical cancer detection. This self-test aims to enhance early intervention and prevention strategies for cervical cancer. The FDA's approval allows for more accessible and convenient screening options for individuals concerned about cervical cancer risks.
May 15, 2024
6 Articles